Cargando…
Apoptotic MSCs and MSC-Derived Apoptotic Bodies as New Therapeutic Tools
Over the past two decades, mesenchymal stem cells (MSCs) have shown promising therapeutic effects both in preclinical studies (in animal models of a wide range of diseases) and in clinical trials. However, the efficacy of MSC-based therapy is not always predictable. Moreover, despite the large numbe...
Autores principales: | Kholodenko, Irina V., Kholodenko, Roman V., Majouga, Alexander G., Yarygin, Konstantin N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688732/ https://www.ncbi.nlm.nih.gov/pubmed/36354663 http://dx.doi.org/10.3390/cimb44110351 |
Ejemplares similares
-
Hepatic Macrophages as Targets for the MSC-Based Cell Therapy in Non-Alcoholic Steatohepatitis
por: Kholodenko, Irina V., et al.
Publicado: (2023) -
Resistance of Human Liver Mesenchymal Stem Cells to FAS-Induced Cell Death
por: Kholodenko, Irina V., et al.
Publicado: (2022) -
The Crosstalk between Mesenchymal Stromal/Stem Cells and Hepatocytes in Homeostasis and under Stress
por: Kholodenko, Irina V., et al.
Publicado: (2023) -
Cellular Mechanisms of Liver Regeneration and Cell-Based Therapies of Liver Diseases
por: Kholodenko, Irina V., et al.
Publicado: (2017) -
Cell Therapy of Stroke: Do the Intra-Arterially Transplanted Mesenchymal Stem Cells Cross the Blood–Brain Barrier?
por: Yarygin, Konstantin N., et al.
Publicado: (2021)